Document is current

Any future updates will be listed below

252 Engineering potent CAR T-cell therapies by controlling T-cell activation signaling parameters using the Stim-R<sup>TM</sup> technology, a programmable synthetic cell-signaling platform

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0252

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark